Status:
WITHDRAWN
Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD
Lead Sponsor:
Osijek University Hospital
Collaborating Sponsors:
Josip Juraj Strossmayer University of Osijek
Conditions:
Postoperative Cognitive Dysfunction
Postoperative Pain, Acute
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This study will examine the effect of intraoperative sedation with midazolam, propofol and dexemdetomidine on the occurrence of postoperative cognitive impairment in patients undergoing surgical treat...
Detailed Description
Patients undergoing surgical treatment of pertrochanteric femoral fracture by intramedullary fixation will be included in the study. Patients will be older than 65 years and will belong to class I to ...
Eligibility Criteria
Inclusion
- Pertrochanteric fracture surgery
- Informed consent signed
Exclusion
- MMSE before surgery \< 17
- Allergy on midazolam, propofol or dexemdetomidine
- Contraindication for neuroaxial anesthesia
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05398757
Start Date
July 1 2022
End Date
March 1 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Osijek
Osijek, Croatia, 31000